SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 3 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,330,000 | -8.4% | 157,066 | -0.1% | 0.63% | -2.6% |
| Q2 2023 | $4,726,000 | -17.5% | 157,216 | -0.6% | 0.65% | -21.2% |
| Q1 2023 | $5,728,000 | -8.2% | 158,094 | -9.6% | 0.82% | -8.7% |
| Q4 2022 | $6,240,000 | +39.0% | 174,946 | +31.9% | 0.90% | +29.4% |
| Q3 2022 | $4,488,000 | +46.2% | 132,598 | +25.0% | 0.70% | +51.1% |
| Q2 2022 | $3,069,000 | – | 106,105 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 698,676 | $41,816,000 | 5.51% |
| Provident Investment Management, Inc. | 543,194 | $32,510,000 | 4.61% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 426,250 | $25,511,000 | 2.37% |
| KOPP INVESTMENT ADVISORS LLC | 41,879 | $2,506,000 | 2.35% |
| AlphaOne Investment Services, LLC | 126,279 | $7,558,000 | 2.17% |
| Ranger Investment Management | 468,933 | $28,066,000 | 1.96% |
| Bruce & Co., Inc. | 158,058 | $9,459,000 | 1.88% |
| Penserra Capital Management LLC | 244,371 | $29,030,000 | 1.83% |
| SHAKER INVESTMENTS LLC/OH | 49,642 | $2,971,000 | 1.83% |
| Bridge City Capital, LLC | 47,795 | $2,861,000 | 1.81% |